Association between carotenoids and outcome of cervical intraepithelial neoplasia: a prospective cohort study

Background It has been suggested that micronutrients such as alpha-tocopherol, retinol, lutein, cryptoxanthin, lycopene, and alpha- and beta-carotene may help in the prevention of cervical cancer. Our aim was to investigate whether serum concentrations and/or dietary intake of micronutrients influen...

Full description

Saved in:
Bibliographic Details
Published inInternational journal of clinical oncology Vol. 18; no. 6; pp. 1091 - 1101
Main Authors Fujii, Takuma, Takatsuka, Naoyoshi, Nagata, Chisato, Matsumoto, Koji, Oki, Akinori, Furuta, Reiko, Maeda, Hiroo, Yasugi, Toshiharu, Kawana, Kei, Mitsuhashi, Akira, Hirai, Yasuo, Iwasaka, Tsuyoshi, Yaegashi, Nobuo, Watanabe, Yoh, Nagai, Yutaka, Kitagawa, Tomoyuki, Yoshikawa, Hiroyuki
Format Journal Article
LanguageEnglish
Published Tokyo Springer Japan 01.12.2013
Springer Nature B.V
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Background It has been suggested that micronutrients such as alpha-tocopherol, retinol, lutein, cryptoxanthin, lycopene, and alpha- and beta-carotene may help in the prevention of cervical cancer. Our aim was to investigate whether serum concentrations and/or dietary intake of micronutrients influence the regression or progression of low-grade cervical abnormalities. Methods In a prospective cohort study of 391 patients with cervical intraepithelial neoplasia (CIN) grade 1–2 lesions, we measured serum micronutrient concentrations in addition to a self-administered questionnaire about dietary intake. We evaluated the hazard ratio (HR) adjusted for CIN grade, human papillomavirus genotype, total energy intake and smoking status. Results In non-smoking regression subjects, regression was significantly associated with serum levels of zeaxanthin/lutein (HR 1.25, 0.78–2.01, p  = 0.024). This benefit was abolished in current smokers. Regression was inhibited by high serum levels of alpha-tocopherol in smokers ( p  = 0.042). In progression subjects, a significant protective effect against progression to CIN3 was observed in individuals with a medium level of serum beta-carotene [HR 0.28, 95 % confidence interval (CI) 0.11–0.71, p  = 0.007), although any protective effect from a higher level of serum beta-carotene was weaker or abolished (HR 0.52, 95 % CI 0.24–1.13, p  = 0.098). Increasing beta-carotene intake did not show a protective effect (HR 2.30, 95 % CI 0.97–5.42, p  = 0.058). Conclusions Measurements of serum levels of carotenoids suggest that regression is modulated by smoking status. Maintaining a medium serum level of beta-carotene has a protective effect for progression; however, carotene intake is not correlated with serum levels of carotenoids.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1341-9625
1437-7772
DOI:10.1007/s10147-012-0486-5